TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T64725	Fatty acid desaturase 2	D0S0RS	MK-8245	Phase 2	24988881	C17H16BrFN6O4	467.2	C1CN(CCC1OC2=C(C=CC(=C2)F)Br)C3=NOC(=C3)C4=NN(N=N4)CC(=O)O	IC50 > 100000000 nM	Non binder
T64725	Fatty acid desaturase 2	B0RNZ6	4-(2-Bromo-5-fluorophenoxy)-1-[5-(2H-tetrazol-5-yl)-1,3,4-thiadiazol-2-yl]piperidine	Investigative	53388366	C14H13BrFN7OS	426.27	C1CN(CCC1OC2=C(C=CC(=C2)F)Br)C3=NN=C(S3)C4=NNN=N4	IC50 > 100000000 nM	Non binder
T64725	Fatty acid desaturase 2	BJC70Y	1-[5-(2H-Tetrazol-5-yl)-1,3,4-thiadiazol-2-yl]-4-[2-(trifluoromethyl)phenoxy]piperidine	Investigative	15980639	C15H14F3N7OS	397.4	C1CN(CCC1OC2=CC=CC=C2C(F)(F)F)C3=NN=C(S3)C4=NNN=N4	IC50 > 100000000 nM	Non binder
T64725	Fatty acid desaturase 2	BN49QM	MF-438	Investigative	16042458	C19H18F3N5OS	421.4	CC1=NN=C(S1)C2=NN=C(C=C2)N3CCC(CC3)OC4=CC=CC=C4C(F)(F)F	IC50 > 100000000 nM	Non binder
T64725	Fatty acid desaturase 2	BP7VY6	2-(5-(5-(4-(2-Bromo-5-fluorophenoxy)piperidin-1-yl)-1,3,4-thiadiazol-2-yl)-2H-tetrazol-2-yl)acetic acid	Investigative	24988880	C16H15BrFN7O3S	484.3	C1CN(CCC1OC2=C(C=CC(=C2)F)Br)C3=NN=C(S3)C4=NN(N=N4)CC(=O)O	IC50 > 100000000 nM	Non binder